v3.25.4
OTHER BALANCE SHEET DETAILS - Schedule of Accrued Expenses (Detail) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Product rebates and discounts $ 400,147 $ 361,816
Compensation and related 257,197 214,399
Preclinical, clinical trial and manufacturing 104,097 75,815
Licensing and collaboration agreements 258,856 92,313
Consulting and professional services 34,328 19,974
Other 25,572 29,375
Total accrued expenses $ 1,080,197 $ 793,692